Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Tracking cell turnover in human brain using 15N-thymidine imaging mass spectrometry

Roeder, Sebastian S. ; Bonnin, Elisa A. ; Wu, Ting Di ; Guerquin-Kern, Jean Luc ; Jabari, Samir ; Brandner, Sebastian ; Eyüpoglu, Ilker Y. ; Gollwitzer, Stephanie ; Hamer, Hajo M. and Gerner, Stefan T. , et al. (2023) In Frontiers in Neuroscience 17.
Abstract

Microcephaly is often caused by an impairment of the generation of neurons in the brain, a process referred to as neurogenesis. While most neurogenesis in mammals occurs during brain development, it thought to continue to take place through adulthood in selected regions of the mammalian brain, notably the hippocampus. However, the generality of neurogenesis in the adult brain has been controversial. While studies in mice and rats have provided compelling evidence for neurogenesis occurring in the adult rodent hippocampus, the lack of applicability in humans of key methods to demonstrate neurogenesis has led to an intense debate about the existence and, in particular, the magnitude of neurogenesis in the adult human brain. Here, we... (More)

Microcephaly is often caused by an impairment of the generation of neurons in the brain, a process referred to as neurogenesis. While most neurogenesis in mammals occurs during brain development, it thought to continue to take place through adulthood in selected regions of the mammalian brain, notably the hippocampus. However, the generality of neurogenesis in the adult brain has been controversial. While studies in mice and rats have provided compelling evidence for neurogenesis occurring in the adult rodent hippocampus, the lack of applicability in humans of key methods to demonstrate neurogenesis has led to an intense debate about the existence and, in particular, the magnitude of neurogenesis in the adult human brain. Here, we demonstrate the applicability of a powerful method to address this debate, that is, the in vivo labeling of adult human patients with 15N-thymidine, a non-hazardous form of thymidine, an approach without any clinical harm or ethical concerns. 15N-thymidine incorporation into newly synthesized DNA of specific cells was quantified at the single-cell level with subcellular resolution by Multiple-isotype imaging mass spectrometry (MIMS) of brain tissue resected for medical reasons. Two adult human patients, a glioblastoma patient and a patient with drug-refractory right temporal lobe epilepsy, were infused for 24 h with 15N-thymidine. Detection of 15N-positive leukocyte nuclei in blood samples from these patients confirmed previous findings by others and demonstrated the appropriateness of this approach to search for the generation of new cells in the adult human brain. 15N-positive neural cells were easily identified in the glioblastoma tissue sample, and the range of the 15N signal suggested that cells that underwent S-phase fully or partially during the 24 h in vivo labeling period, as well as cells generated therefrom, were detected. In contrast, within the hippocampus tissue resected from the epilepsy patient, none of the 2,000 dentate gyrus neurons analyzed was positive for 15N-thymidine uptake, consistent with the notion that the rate of neurogenesis in the adult human hippocampus is rather low. Of note, the likelihood of detecting neurogenesis was reduced because of (i) the low number of cells analyzed, (ii) the fact that hippocampal tissue was explored that may have had reduced neurogenesis due to epilepsy, and (iii) the labeling period of 24 h which may have been too short to capture quiescent neural stem cells. Yet, overall, our approach to enrich NeuN-labeled neuronal nuclei by FACS prior to MIMS analysis provides a promising strategy to quantify even low rates of neurogenesis in the adult human hippocampus after in vivo15N-thymidine infusion. From a general point of view and regarding future perspectives, the in vivo labeling of humans with 15N-thymidine followed by MIMS analysis of brain tissue constitutes a novel approach to study mitotically active cells and their progeny in the brain, and thus allows a broad spectrum of studies of brain physiology and pathology, including microcephaly.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
adult, cell turnover, DNA-labeling, glioblastoma, hippocampus, Nano-SIMS, neurogenesis
in
Frontiers in Neuroscience
volume
17
article number
1274607
publisher
Frontiers Media S. A.
external identifiers
  • pmid:37869505
  • scopus:85174563731
ISSN
1662-4548
DOI
10.3389/fnins.2023.1274607
language
English
LU publication?
yes
additional info
Publisher Copyright: Copyright © 2023 Roeder, Bonnin, Wu, Guerquin-Kern, Jabari, Brandner, Eyüpoglu, Gollwitzer, Hamer, Gerner, Döppner, Rummel, Englund, Heimke-Brinck, Borst, Daniel, Amann, Schlötzer-Schrehardt, Tonchev, Roessler, Schwab, Bergmann, Rizzoli and Huttner.
id
32d4f2e5-4991-48ba-9a1e-0ce06121ccaa
date added to LUP
2023-12-20 15:51:15
date last changed
2024-04-19 01:22:34
@article{32d4f2e5-4991-48ba-9a1e-0ce06121ccaa,
  abstract     = {{<p>Microcephaly is often caused by an impairment of the generation of neurons in the brain, a process referred to as neurogenesis. While most neurogenesis in mammals occurs during brain development, it thought to continue to take place through adulthood in selected regions of the mammalian brain, notably the hippocampus. However, the generality of neurogenesis in the adult brain has been controversial. While studies in mice and rats have provided compelling evidence for neurogenesis occurring in the adult rodent hippocampus, the lack of applicability in humans of key methods to demonstrate neurogenesis has led to an intense debate about the existence and, in particular, the magnitude of neurogenesis in the adult human brain. Here, we demonstrate the applicability of a powerful method to address this debate, that is, the in vivo labeling of adult human patients with <sup>15</sup>N-thymidine, a non-hazardous form of thymidine, an approach without any clinical harm or ethical concerns. <sup>15</sup>N-thymidine incorporation into newly synthesized DNA of specific cells was quantified at the single-cell level with subcellular resolution by Multiple-isotype imaging mass spectrometry (MIMS) of brain tissue resected for medical reasons. Two adult human patients, a glioblastoma patient and a patient with drug-refractory right temporal lobe epilepsy, were infused for 24 h with <sup>15</sup>N-thymidine. Detection of <sup>15</sup>N-positive leukocyte nuclei in blood samples from these patients confirmed previous findings by others and demonstrated the appropriateness of this approach to search for the generation of new cells in the adult human brain. <sup>15</sup>N-positive neural cells were easily identified in the glioblastoma tissue sample, and the range of the <sup>15</sup>N signal suggested that cells that underwent S-phase fully or partially during the 24 h in vivo labeling period, as well as cells generated therefrom, were detected. In contrast, within the hippocampus tissue resected from the epilepsy patient, none of the 2,000 dentate gyrus neurons analyzed was positive for <sup>15</sup>N-thymidine uptake, consistent with the notion that the rate of neurogenesis in the adult human hippocampus is rather low. Of note, the likelihood of detecting neurogenesis was reduced because of (i) the low number of cells analyzed, (ii) the fact that hippocampal tissue was explored that may have had reduced neurogenesis due to epilepsy, and (iii) the labeling period of 24 h which may have been too short to capture quiescent neural stem cells. Yet, overall, our approach to enrich NeuN-labeled neuronal nuclei by FACS prior to MIMS analysis provides a promising strategy to quantify even low rates of neurogenesis in the adult human hippocampus after in vivo<sup>15</sup>N-thymidine infusion. From a general point of view and regarding future perspectives, the in vivo labeling of humans with <sup>15</sup>N-thymidine followed by MIMS analysis of brain tissue constitutes a novel approach to study mitotically active cells and their progeny in the brain, and thus allows a broad spectrum of studies of brain physiology and pathology, including microcephaly.</p>}},
  author       = {{Roeder, Sebastian S. and Bonnin, Elisa A. and Wu, Ting Di and Guerquin-Kern, Jean Luc and Jabari, Samir and Brandner, Sebastian and Eyüpoglu, Ilker Y. and Gollwitzer, Stephanie and Hamer, Hajo M. and Gerner, Stefan T. and Döppner, Thorsten R. and Rummel, Christoph and Englund, Elisabet and Heimke-Brinck, Ralph and Borst, Tobias and Daniel, Christoph and Amann, Kerstin and Schlötzer-Schrehardt, Ursula and Tonchev, Anton B. and Roessler, Karl and Schwab, Stefan and Bergmann, Olaf and Rizzoli, Silvio O. and Huttner, Hagen B.}},
  issn         = {{1662-4548}},
  keywords     = {{adult; cell turnover; DNA-labeling; glioblastoma; hippocampus; Nano-SIMS; neurogenesis}},
  language     = {{eng}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Neuroscience}},
  title        = {{Tracking cell turnover in human brain using <sup>15</sup>N-thymidine imaging mass spectrometry}},
  url          = {{http://dx.doi.org/10.3389/fnins.2023.1274607}},
  doi          = {{10.3389/fnins.2023.1274607}},
  volume       = {{17}},
  year         = {{2023}},
}